CSIMarket
 


West Pharmaceutical Services Inc   (WST)
Other Ticker:  
 

Cumulative West Pharmaceutical Services Inc 's Total Debt to Equity for Trailing Twelve Months Period

WST's Total Debt to Equity for Trailing Twelve Months Period and Total Debt, Equity growth


Select the Comparisons : Select the Ratio:

WST Total Debt to Equity for Trailing Twelve Months Period

(Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Equity Growth 7.3 % 16.08 % 13.29 % 19.34 % 14.97 %
Y / Y Total Debt Growth -64.78 % -27.36 % -1.06 % -1.06 % -1.01 %
Total Debt to Equity for Trailing Twelve Months Period 0.06 0.07 0.08 0.08 0.08
Total Ranking # 220 # 404 # 475 # 500 # 653
Seq. Equity Growth 0.45 % 4.42 % -1.06 % 3.4 % 8.67 %
Seq. Total Debt Growth -52.14 % -26.02 % -0.24 % -0.29 % -1.29 %


Total Debt to Equity for Trailing Twelve Months Period Comment for 12 Months ending at Dec 31 2023
On the trailing twelve months basis Due to repayements of liabilities of -52.14% West Pharmaceutical Services Inc decreased Total Debt to Equity for Trailing Twelve Months Period in the IV. Quarter to 0.06, below company's average Total Debt to Equity for Trailing Twelve Months Period.
Total Debt to Equity for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies in Medical Equipment & Supplies industry 4 other companies have achieved lower Total Debt to Equity for Trailing Twelve Months Period than West Pharmaceutical Services Inc . While total ranking remained unchanged compare to previous quarter at no. .

What is Debt to Equity Ratio?
WST Charts and Quotes
Total Debt to Equity WST in the most recent quarter
Total Debt to Equity for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 5
Sector # 29
S&P 500 # 130


Total Debt to Equity for Trailing Twelve Months Period Statistics
High Average Low
0.18 0.09 0
(Dec 31 2017)   (Dec 31 2016)




Companies with similar average Total Debt to Equity for Trailing Twelve Months Period for 12 months ending Dec 31 2023, within Medical Equipment & Supplies Industry Total Debt to Equity for Trailing Twelve Months Period
Cytosorbents Corporation  0.14 
Escalon Medical Corp   0.12 
Atricure Inc   0.12 
Star Equity Holdings Inc   0.11 
Enovis Corporation  0.10 
Edap Tms Sa  0.10 
Inovio Pharmaceuticals Inc   0.10 
Edwards Lifesciences Corporation  0.09 
Sanara Medtech Inc   0.09 
Orchestra Biomed Holdings Inc   0.08 
Biolife Solutions Inc   0.07 
Orthofix Medical Inc   0.07 
Dynatronics Corporation  0.07 
Globus Medical Inc   0.07 
Genedx Holdings Corp   0.07 
Angiodynamics Inc   0.06 
Nexalin Technology Inc   0.06 
West Pharmaceutical Services Inc   0.06 
Meihua International Medical Technologies Co Ltd   0.05 
Alpha Tau Medical Ltd   0.05 
Endra Life Sciences Inc   0.04 
Ir med Inc   0.04 
Nexgel Inc   0.04 
Sintx Technologies Inc   0.02 
Nutriband Inc   0.02 
Stevanato Group S p a   0.02 
Docgo Inc   0.02 
Perspective Therapeutics Inc   0.02 
Retractable Technologies inc   0.02 
Universal Biosensors Inc   0.02 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com